Vis enkel innførsel

dc.contributor.authorEngseth, Tina Pettersen
dc.contributor.authorAndersson, Erik P
dc.contributor.authorSolli, Guro Strøm
dc.contributor.authorMorseth, Bente
dc.contributor.authorThomassen, Tor Oskar
dc.contributor.authorNoordhof, Dionne
dc.contributor.authorSandbakk, Øyvind
dc.contributor.authorWelde, Boye
dc.date.accessioned2022-08-17T11:39:45Z
dc.date.available2022-08-17T11:39:45Z
dc.date.issued2022-04-14
dc.description.abstractPurpose: To investigate the prevalence of hormonal contraceptive (HC) use by female cross-country (XC) skiers and biathletes competing at a national and/or international level, their reasons for HC use, and to compare negative symptoms related to the HC-/menstrual cycle in HC users and non-HC users. Additionally, to characterize the self-perceived influence of HC use on training and performance.<p> <p>Methods: A total of 113 Norwegian competitive XC skiers and biathletes completed an online questionnaire including both closed and open-ended questions. The questions were designed to assess the type of HC, reasons for use, self-reported negative symptoms related to HC-/menstrual cycle, as well as athletes' experiences regarding how HC use affects training and performance.<p> <p>Results: In total, 68% of all the athletes used HC, with 64 and 36% of them using a progestin-only and combined type HC, respectively. Non-contraceptive reasons for HC use were reported by 51% of the progestin-only HC users vs. 75% of the combined HC users (P = 0.039), with reduction of negative menstrual-related symptoms as the most common reason. Of the athletes reporting regular withdrawal bleedings in connection to HC use, 80% of the progestin-only and 86% of combined HC users experienced negative menstrual-related symptoms, which was comparable to the non-HC group (86%). The majority (81%) of HC users experienced solely positive, or no effect, of HC use on training and performance, with no differences between progestin-only and combined HC users (P = 0.942).<p> <p>Conclusions: In total, 68% of the XC skiers and biathletes used HC, with the highest proportion (64%) using a progestin-only HC. Many athletes used HC to manipulate their menstrual cycle due to perceived negative menstrual-related symptoms that interfered with their training sessions and/or competitions.en_US
dc.identifier.citationEngseth T, Andersson E, Solli GS, Morseth B, Thomassen TO, Noordhof D. A., Sandbakk Ø, Welde B. Prevalence and Self-Perceived Experiences With the Use of Hormonal Contraceptives Among Competitive Female Cross-Country Skiers and Biathletes in Norway: The FENDURA Project. Frontiers in Sports and Active Living. 2022;4en_US
dc.identifier.cristinIDFRIDAID 2017878
dc.identifier.doi10.3389/fspor.2022.873222
dc.identifier.issn2624-9367
dc.identifier.urihttps://hdl.handle.net/10037/26238
dc.language.isoengen_US
dc.publisherFrontiers Mediaen_US
dc.relation.ispartofEngseth, T.P. (2024). The perception of the menstrual cycle, cycle-related symptoms, and hormonal contraception in female endurance athletes: The FENDURA project. (Doctoral thesis). <a href=https://hdl.handle.net/10037/33779>https://hdl.handle.net/10037/33779</a>
dc.relation.journalFrontiers in Sports and Active Living
dc.relation.projectIDTromsø forskningsstiftelse: 19_FENDURA_BWen_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2022 The Author(s)en_US
dc.titlePrevalence and Self-Perceived Experiences With the Use of Hormonal Contraceptives Among Competitive Female Cross-Country Skiers and Biathletes in Norway: The FENDURA Projecten_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel